Patient preferences regarding side effects of chemotherapy for ovarian cancer: do they change over time?
about
Patient-centered management of chemotherapy-induced nausea and vomitingEmerging therapies for the prevention and treatment of oral mucositis.Therapy preferences in melanoma treatment--willingness to pay and preference of quality versus length of life of patients, physicians and healthy controls.Patient preferences for side effects associated with cervical cancer treatmentPatient preferences for chemotherapies used in breast cancer.Supportive care for women with gynecologic cancers.Cost-effectiveness of an aprepitant regimen for prevention of chemotherapy-induced nausea and vomiting in patients with breast cancer in the UKDetermination of quality of life-related utilities for health states relevant to ovarian cancer diagnosis and treatment.Adherence of Primary Care Physicians to Evidence-Based Recommendations to Reduce Ovarian Cancer Mortality.A review of cost-effectiveness studies in ovarian cancer.Attitudes toward disclosure of medication side effects: a nationwide survey of Korean patients, caregivers, and oncologists.Assessment of factors that contribute to decreased quality of life in Gynecologic Oncology Group ovarian cancer trialsCost-effectiveness of aprepitant in Japanese patients treated with cisplatin-containing highly emetogenic chemotherapy
P2860
Q26828354-183AAC9F-DB91-4BBC-96D4-B297B562A3FBQ34432808-CF753828-4730-413B-A43E-E127E96BFA60Q34450266-F4D4E1B6-6B7D-45CE-ABB0-E12D91AF81A9Q34871388-131326AF-C68F-496A-A997-2D216A49DA35Q36136363-D20364EA-E168-42CE-AE1E-7A15C1546A95Q37086010-066DC713-9C4E-48A3-ADCE-703ACD913426Q37091366-D3FB5E19-45C8-4B47-ABCA-AA929C701265Q37269617-07CCE44C-A27A-474F-8E8A-4BBDD0C6F85FQ37621808-5DBEEB29-D50E-47D0-8FBB-695356552A30Q37832934-C2805A45-5F5D-45AD-BD2E-C46C6EBEBC83Q40943526-4298AE2C-BADA-47C5-8179-290BA3D46FFFQ57903787-A43BD1A4-A6DD-4A0C-9680-F0C56C934E7BQ58800927-943E3C89-700A-46FB-86AC-431A4FBB5C3E
P2860
Patient preferences regarding side effects of chemotherapy for ovarian cancer: do they change over time?
description
2002 nî lūn-bûn
@nan
2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Patient preferences regarding ...... cer: do they change over time?
@ast
Patient preferences regarding ...... cer: do they change over time?
@en
type
label
Patient preferences regarding ...... cer: do they change over time?
@ast
Patient preferences regarding ...... cer: do they change over time?
@en
prefLabel
Patient preferences regarding ...... cer: do they change over time?
@ast
Patient preferences regarding ...... cer: do they change over time?
@en
P2093
P921
P356
P1433
P1476
Patient preferences regarding ...... cer: do they change over time?
@en
P2093
Candice L Borden
Charlotte C Sun
David M Gershenson
Edward B Rubenstein
John J Kavanagh
Mark F Munsell
Michele L Donato
P304
P356
10.1006/GYNO.2002.6807
P407
P577
2002-10-01T00:00:00Z